Effect of 4-Hydroxy-2-nonenal Modification on {alpha}-Synuclein Aggregation
Qin et al.
J. Biol. Chem. 2007;282:5862-5870.
ABSTRACT
| FULL TEXT
Translational Research on the Way to Effective Therapy for Alzheimer Disease
Rosenberg
Arch Gen Psychiatry 2005;62:1186-1192.
ABSTRACT
| FULL TEXT
Mechanisms of Soluble {beta}-Amyloid Impairment of Endothelial Function
Gentile et al.
J. Biol. Chem. 2004;279:48135-48142.
ABSTRACT
| FULL TEXT
Nutrition- and Virus-Induced Stress Represses the Expression of Manganese Superoxide Dismutase in Vitro
Berger et al.
Exp. Biol. Med. 2004;229:843-849.
ABSTRACT
| FULL TEXT
Alzheimer Disease: Mechanistic Understanding Predicts Novel Therapies
Selkoe
ANN INTERN MED 2004;140:627-638.
FULL TEXT
Amyloid-{beta} peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway
Lee et al.
J. Cell Biol. 2004;164:123-131.
ABSTRACT
| FULL TEXT
The Role of the Presenilin-1 Homologue Gene sel-12 of Caenorhabditis elegans in Apoptotic Activities
Kitagawa et al.
J. Biol. Chem. 2003;278:12130-12134.
ABSTRACT
| FULL TEXT
Lymphocyte Oxidative DNA Damage and Plasma Antioxidants in Alzheimer Disease
Mecocci et al.
Arch Neurol 2002;59:794-798.
ABSTRACT
| FULL TEXT
Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle
Jaworska-Wilczynska et al.
Neurology 2002;58:438-445.
ABSTRACT
| FULL TEXT
Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease
Adair et al.
Neurology 2001;57:1515-1517.
ABSTRACT
| FULL TEXT
Association of Active Extracellular Signal-Regulated Protein Kinase with Paired Helical Filaments of Inclusion-Body Myositis Muscle Suggests Its Role in Inclusion-Body Myositis Tau Phosphorylation
Wilczynski et al.
Am. J. Pathol. 2000;156:1835-1840.
ABSTRACT
| FULL TEXT
Amyloid-{beta} Peptides Are Cytotoxic to Oligodendrocytes
Xu et al.
J. Neurosci. 2001;21:RC118-RC118.
ABSTRACT
| FULL TEXT